It is important to expand clinical trial access for patients with kidney cancer in order to ensure a representative study population.

Intensive chemotherapy improved survival in patients with accelerated and blast phase myeloproliferative neoplasms, with ...

A diagnosis of breast cancer isn’t something most people would think of as a teacher, but sometimes important lessons come to ...

Cancer treatments can speed up aging in survivors, according to research, which can contribute to a person's risk for ...

The FDA has granted fast track designation to HLD-0915 for metastatic castration-resistant prostate cancer. The U.S. Food and ...

The accelerated approval of Modeyso for diffuse midline glioma with an H3 K27M mutation, is a step in the right direction but ...

Breast cancer survivor and researcher LaShae Rolle studies how individualized strength training during chemo boosts physical, ...

Dr. Jim Omel, who was diagnosed with multiple myeloma in 1997, explained how the treatment landscape has changed over nearly ...

More than half of patients with low platelets treated with Vonjo had a platelet response, with median platelets rising 58% and hemoglobin increasing.

Living with stage 4 cancer taught me the power of community; connecting with others provides guidance, support, and hope in ...

Real-world data show that Enhertu benefits those with HR+ breast cancer, whereas Trodelvy is effective as an initial treatment for HER2-null/HER2– disease.

Dr. Jacob Sands explained that he believes patients should be having more personalized, nuanced conversations with their ...